Patent details

EP3773589 Title: RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION

Basic Information

Publication number:
EP3773589
PCT Application Number:
US2019025655
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197185317
PCT Publication Number:
WO2019195471
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
French Title of Invention:
INHIBITEUR DE RET DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU CANCER PRÉSENTANT UNE ALTÉRATION DU RET
German Title of Invention:
RET-INHIBITOR ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS MIT EINER RET-VERÄNDERUNG
SPC Number:

Dates

Filing date:
03/04/2019
Grant date:
01/11/2023
EP Publication Date:
17/02/2021
PCT Publication Date:
10/10/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/11/2023
EP B1 Publication Date:
01/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/04/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2023
 
 

Name:
Blueprint Medicines Corporation
Address:
45 Sidney Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/01/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WOLF, Beni B.
Address:
United States (US)

2

Name:
EVANS RAAB, Erica
Address:
United States (US)

Priority

1

Priority Number:
201862652284 P
Priority Date:
03/04/2018
Priority Country:
United States (US)

2

Priority Number:
201862656297 P
Priority Date:
11/04/2018
Priority Country:
United States (US)

3

Priority Number:
201862657605 P
Priority Date:
13/04/2018
Priority Country:
United States (US)

4

Priority Number:
201862741683 P
Priority Date:
05/10/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/506; A61K 45/06; A61P 35/04; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202344
Publication date:
01/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/03/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
18/01/2024 Power Of Attorney 1
19/01/2024 Outgoing Correspondence 1